We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Lockheed Martin Wins Deal to Support F-35 Aircraft Program
Read MoreHide Full Article
Lockheed Martin Corp.’s (LMT - Free Report) business segment, Aeronautics, recently secured a modification contract for providing sustainment support to all Australia, Canada, United Kingdom Reprogramming Laboratory (ACURL) systems for including consumables pertaining to the F-35 aircraft program. The deal has been awarded by the Naval Air Systems Command, Patuxent River, Maryland.
Valued at $18 million, the contract will cater to the governments of Australia, Canada and the United Kingdom. Work related to the deal is scheduled to be over by February 2021 and will be carried out in Eglin, FL.
Importance of F-35 in the Fighter Jet Market
With increased cross-border tensions gripping varied nations across the globe, both developed and developing nations have been ramping up their defense arsenal over the past decade. Notably, military jets comprise major part of the weapon portfolio.
At present, Lockheed Martin’s supersonic, multi-role fighter jet, F-35, is being used by the defense forces of the United States and 11 other nations.
According to Forecast International, a total of 3,401 fighter aircraft are expected to be produced from 2019 through 2028. Notably, the total number of fighters to be produced over the next decade is 17.2% higher than the number of aircraft produced during the previous 10 years. F-35 is anticipated to be the largest fighter program over the next decade.
Of the nearly 3,400 fighters expected to enter the production lines during the next 10 years, 1,548 jets are expected to be F-35s, representing 45.5% of the market. This clearly highlights the importance of the F-35 program in the global fighter jet market.
What Favors Lockheed Martin?
The F-35 is Lockheed Martin’s largest program that generates more than 25% of its total sales. Last year, the program fueled annual revenue growth by 19.6% at the company’s Aeronautics division. Keeping up with this trend, we may expect the latest contract win to help the Aeronautics unit deliver similar or even better performance in the upcoming quarters.
Taking into account the F-35 program’s solid estimated production rate, as mentioned above, the latest contract win should further provide a boost to this program in the coming days.
Such developments reflect solid prospects for Lockheed Martin’s F-35 program, which are likely to bolster the company’s profit margin.
Price Movement
In a year’s time, shares of Lockheed Martin have gained 31.3% compared with the industry’s 19.2% growth.
L3Harris’ long-term growth estimate currently stands at 10.4%. The company delivered average positive earnings surprise of 5.02% in the last four quarters.
Leidos delivered average positive earnings surprise of 8.93% in the last four quarters. Its long-term growth estimate currently stands at 7.5%.
Air Industries Group delivered average positive earnings surprise of 52.78% in the last four quarters. The Zacks Consensus Estimate for 2019 loss has increased 63.6% to 4 cents over the past 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
Lockheed Martin Wins Deal to Support F-35 Aircraft Program
Lockheed Martin Corp.’s (LMT - Free Report) business segment, Aeronautics, recently secured a modification contract for providing sustainment support to all Australia, Canada, United Kingdom Reprogramming Laboratory (ACURL) systems for including consumables pertaining to the F-35 aircraft program. The deal has been awarded by the Naval Air Systems Command, Patuxent River, Maryland.
Valued at $18 million, the contract will cater to the governments of Australia, Canada and the United Kingdom. Work related to the deal is scheduled to be over by February 2021 and will be carried out in Eglin, FL.
Importance of F-35 in the Fighter Jet Market
With increased cross-border tensions gripping varied nations across the globe, both developed and developing nations have been ramping up their defense arsenal over the past decade. Notably, military jets comprise major part of the weapon portfolio.
At present, Lockheed Martin’s supersonic, multi-role fighter jet, F-35, is being used by the defense forces of the United States and 11 other nations.
According to Forecast International, a total of 3,401 fighter aircraft are expected to be produced from 2019 through 2028. Notably, the total number of fighters to be produced over the next decade is 17.2% higher than the number of aircraft produced during the previous 10 years. F-35 is anticipated to be the largest fighter program over the next decade.
Of the nearly 3,400 fighters expected to enter the production lines during the next 10 years, 1,548 jets are expected to be F-35s, representing 45.5% of the market. This clearly highlights the importance of the F-35 program in the global fighter jet market.
What Favors Lockheed Martin?
The F-35 is Lockheed Martin’s largest program that generates more than 25% of its total sales. Last year, the program fueled annual revenue growth by 19.6% at the company’s Aeronautics division. Keeping up with this trend, we may expect the latest contract win to help the Aeronautics unit deliver similar or even better performance in the upcoming quarters.
Taking into account the F-35 program’s solid estimated production rate, as mentioned above, the latest contract win should further provide a boost to this program in the coming days.
Such developments reflect solid prospects for Lockheed Martin’s F-35 program, which are likely to bolster the company’s profit margin.
Price Movement
In a year’s time, shares of Lockheed Martin have gained 31.3% compared with the industry’s 19.2% growth.
Zacks Rank & Key Picks
Lockheed Martin currently carries a Zacks Rank #3 (Hold). A few better-ranked stocks in the same space are L3Harris Technology Inc (LHX - Free Report) , Leidos Holdings, Inc. (LDOS - Free Report) and Air Industries Group (AIRI - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
L3Harris’ long-term growth estimate currently stands at 10.4%. The company delivered average positive earnings surprise of 5.02% in the last four quarters.
Leidos delivered average positive earnings surprise of 8.93% in the last four quarters. Its long-term growth estimate currently stands at 7.5%.
Air Industries Group delivered average positive earnings surprise of 52.78% in the last four quarters. The Zacks Consensus Estimate for 2019 loss has increased 63.6% to 4 cents over the past 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>